The fatal, progressive neurological condition currently affects around 5,000 people in the UK. Researchers from the University of Edinburgh and the University of ...

The third most common and serious form of cancer affects over 43,000 people every year in the UK. In partnership between The Royal Marsden and Guardant Health, re...

The progressive neurodegenerative disease is estimated to affect 24 million people globally. Researchers from the University of British Columbia in Canada have re...

The genetic condition affects one in 279 people in England and significantly increases cancer risk Researchers from the Institute of Cancer Research (ICR), in col...

Two out of three people with the neurodegenerative condition experienced delirium in hospital. Researchers from Newcastle University have revealed that people liv...

The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases. Strand Therapeutics, a Massachusetts Institute of Tech...

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m. The University of Liverpool has announced that it will be ...

Stäubli Robotics to show automation solutions for all GMP grades at ACHEMA 2024 ACHEMA, a global forum for process industries, is coming to Frankfurt am Main, Ger...

Highlights include environmental goals based on climate science, workforce empowerment, focus on local partnerships, and supply chain resiliency. PCI Pharma Servi...

The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) brings together esteemed regional partners with the mission to transform the industry with gre...